Showing 1 - 8 results of 8 for search 'E. I. Kovalenko', query time: 0.03s
Refine Results
-
1
-
2
-
3
CDK4/6 inhibitors in the treatment of metastatic breast cancer. Choosing optimal therapy for estrogen-receptor-positive HER2-negative metastatic breast cancer: analysis of doctors’... by E. V. Artamonova, E. I. Kovalenko, L. V. Bolotina, M. B. Stenina, R. V. Orlova, M. A. Mukhina
Published 2021-01-01Get full text
Article -
4
Effectiveness of cyclin-dependent kinase 4 and 6 inhibitors for the treatment of hormonesensitive HER2-negative metastatic breast cancer in first-line therapy: A systematic literat... by N. A. Avxentyev, I. I. Andreyashkina, E. V. Artamonova, L. V. Bolotina, E. I. Kovalenko, N. N. Sisigina
Published 2024-05-01Get full text
Article -
5
DISTRIBUTION OF <i>MICA</i> ALLELES IN THE RUSSIAN POPULATION by L. M. Kanevskiy, M. V. Grechikhina, E. G. Kuzmina, T. Yu. Mushkarina, A. A. Spelkov, M. A. Streltsova, E. I. Kovalenko
Published 2019-12-01Get full text
Article -
6
Clinical significance of changes in the expression level of markers of surrogate breast cancer subtypes in recurrent and metastatic foci (literature review) by Yu. S. Krumin, V. A. Khaylenko, N. A. Kozlov, G. Yu. Cheremis, A. V. Petrovskyy, D. V. Khaylenko, E. V. Artamonova, E. I. Kovalenko
Published 2021-03-01Get full text
Article -
7
TREATMENT OF BREAST CANCER WITH METASTATIC CONTRALATERAL AXILLARY LYMPH NODES: CASE REPORT AND LITERATURE REVIEW by V. A. Amosova, A. V. Petrovsky, M. V. Chernykh, E. I. Kovalenko, M. A. Frolova, R. K. Valiev, M. I. Nechushkin, V. U. Kirsanov, I. V. Vysotskaya, D. E. Avtomonov
Published 2020-01-01Get full text
Article -
8
Microenvironment-related predictive markers of the therapeutic effectiveness of eribulin in patients with locally advanced or metastatic breast cancer: pilot study by L. A. Tashireva, N. O. Popova, V. V. Alifanov, V. E. Goldberg, E. I. Kovalenko, E. V. Artamonova, A. G. Manikhas, D. M. Ponomarenko, N. V. Levchenko, E. I. Rossokha, S. Yu. Krasilnikova, M. A. Zafirova, V. M. Perelmuter
Published 2022-01-01Get full text
Article